Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Fiegl, Michael"" wg kryterium: Autor


Wyświetlanie 1-18 z 18
Tytuł:
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations.
Autorzy:
Gamerith G; Department of Haematology and Oncology, Clinic of Internal Medicine V, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Kloppenburg M; Clinic of Otorhinolaryngology-Head & Neck Surgery, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Mildner F; Department of Haematology and Oncology, Clinic of Internal Medicine V, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Amann A; Department of Haematology and Oncology, Clinic of Internal Medicine V, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Merkelbach-Bruse S; Institute of Pathology, University Hospital Cologne, 50937 Cologne, Germany.
Heydt C; Institute of Pathology, University Hospital Cologne, 50937 Cologne, Germany.
Siemanowski J; Institute of Pathology, University Hospital Cologne, 50937 Cologne, Germany.
Buettner R; Institute of Pathology, University Hospital Cologne, 50937 Cologne, Germany.
Fiegl M; Department of Haematology and Oncology, Clinic of Internal Medicine V, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Clinic Hochrum, 6063 Rum, Austria.
Manzl C; Institute of Pathology, Neuropathology and Molecularpathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Pall G; Department of Haematology and Oncology, Clinic of Internal Medicine V, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Oct 19; Vol. 14 (20). Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent.
Autorzy:
Kocher F; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, 6020 Innsbruck, Austria.
Mian M; Department of Hematology & CBMT, Central Hospital of Bolzano (SABES-ASDAA), 39100 Bolzano-Bozen, Italy.; Riga Stradiņš University, 1007 Riga, Latvia.
Seeber A; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, 6020 Innsbruck, Austria.
Fiegl M; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, 6020 Innsbruck, Austria.
Stauder R; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, 6020 Innsbruck, Austria.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2020 Apr 02; Vol. 9 (4). Date of Electronic Publication: 2020 Apr 02.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Diagnostic and prognostic impact of mucin 1-6 expression in non-small cell lung cancer.
Autorzy:
Sterlacci W; Department of Pathology, Hospital Bayreuth, Bayreuth, Germany.
Fiegl M; Department of Internal Medicine, Division of Hematology and Oncology, Medical University Innsbruck, Innsbruck; Department of Internal Medicine, Oncology and Geriatrics, Hospital Hochrum, Rum, Austria.
Veits L; Department of Pathology, Hospital Bayreuth, Bayreuth, Germany.
Tzankov A; Department of Pathology, University Hospital Basel, Basel, Switzerland.
Pokaż więcej
Źródło:
Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2018 Apr-Jun; Vol. 61 (2), pp. 187-191.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor/*analysis
Carcinoma, Non-Small-Cell Lung/*pathology
Lung Neoplasms/*pathology
Mucin 5AC/*metabolism
Mucin-1/*metabolism
Mucin-2/*metabolism
Mucin-4/*metabolism
Mucin-6/*metabolism
Carcinoma, Non-Small-Cell Lung/mortality ; Humans ; Immunohistochemistry ; Lung Neoplasms/mortality ; Neovascularization, Pathologic/pathology ; Prognosis ; Thyroid Nuclear Factor 1/genetics
Czasopismo naukowe
Tytuł:
Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.
Autorzy:
Berking S; Department of Internal Medicine III, Hospital of the University of Munich, Munich, Germany.
Doedens D; Department of Internal Medicine III, Hospital of the University of Munich, Munich, Germany.
Horns H; Department of Internal Medicine III, Hospital of the University of Munich, Munich, Germany.
Fiegl M; Haematology and Oncology Teaching Practice, Ludwig-Maximilians-University of Munich, Germering, Germany.
Ostermann H; Department of Internal Medicine III, Hospital of the University of Munich, Munich, Germany.
Rieger CT; Department of Internal Medicine III, Hospital of the University of Munich, Munich, Germany.; Haematology and Oncology Teaching Practice, Ludwig-Maximilians-University of Munich, Germering, Germany.
Pokaż więcej
Źródło:
Mycoses [Mycoses] 2017 Sep; Vol. 60 (9), pp. 600-606. Date of Electronic Publication: 2017 May 15.
Typ publikacji:
Journal Article
MeSH Terms:
Guideline Adherence*
Antifungal Agents/*therapeutic use
Leukemia, Myeloid, Acute/*microbiology
Mycoses/*prevention & control
Adult ; Aged ; Antifungal Agents/administration & dosage ; Female ; Fluconazole/administration & dosage ; Fluconazole/therapeutic use ; Galactose/analogs & derivatives ; Guidelines as Topic ; Humans ; Leukemia, Myeloid, Acute/complications ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/drug therapy ; Male ; Mannans/blood ; Middle Aged ; Pre-Exposure Prophylaxis ; Retrospective Studies ; Triazoles/administration & dosage ; Triazoles/therapeutic use
Czasopismo naukowe
Tytuł:
Expression of PD-L1 Identifies a Subgroup of More Aggressive Non-Small Cell Carcinomas of the Lung.
Autorzy:
Sterlacci W; Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany.
Fiegl M
Droeser RA
Tzankov A
Pokaż więcej
Źródło:
Pathobiology : journal of immunopathology, molecular and cellular biology [Pathobiology] 2016; Vol. 83 (5), pp. 267-75. Date of Electronic Publication: 2016 May 27.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma/*diagnosis
B7-H1 Antigen/*metabolism
Biomarkers, Tumor/*metabolism
Carcinoma, Non-Small-Cell Lung/*diagnosis
Lung Neoplasms/*diagnosis
Adenocarcinoma/metabolism ; Aged ; B7-H1 Antigen/immunology ; CD8-Positive T-Lymphocytes ; Carcinoma, Non-Small-Cell Lung/metabolism ; Cohort Studies ; Female ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Lung Neoplasms/metabolism ; Lymphocytes, Tumor-Infiltrating ; Male ; Middle Aged ; Prognosis ; Survival Analysis ; Tissue Array Analysis
Czasopismo naukowe
Tytuł:
Weight Loss and Decrease of Body Mass Index during Allogeneic Stem Cell Transplantation Are Common Events with Limited Clinical Impact.
Autorzy:
Rieger CT; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Wischumerski I; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Rust C; Department of Internal Medicine I, Krankenhaus der Barmherzigen Brüder, Munich, Germany.
Fiegl M; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Dec 18; Vol. 10 (12), pp. e0145445. Date of Electronic Publication: 2015 Dec 18 (Print Publication: 2015).
Typ publikacji:
Journal Article
MeSH Terms:
Stem Cell Transplantation*
Adult ; Aged ; Body Mass Index ; Female ; Humans ; Leukemia, Myeloid, Acute/pathology ; Leukemia, Myeloid, Acute/therapy ; Male ; Middle Aged ; Transplantation, Homologous ; Treatment Outcome ; Weight Loss ; Young Adult
Czasopismo naukowe
Tytuł:
IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Autorzy:
Kuett A; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Rieger C; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Perathoner D; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Herold T; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Wagner M; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Sironi S; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Sotlar K; Institute of Pathology, Klinikum der Universität München, Munich, Germany.
Horny HP; Institute of Pathology, Klinikum der Universität München, Munich, Germany.
Deniffel C; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Drolle H; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Fiegl M; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2015 Dec 17; Vol. 5, pp. 18411. Date of Electronic Publication: 2015 Dec 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Marrow/*metabolism
Interleukin-8/*genetics
Leukemia, Myeloid, Acute/*genetics
Stem Cell Niche/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Bone Marrow/pathology ; Bone Marrow Cells/metabolism ; Cell Line, Tumor ; Enzyme-Linked Immunosorbent Assay ; Female ; Gene Expression Regulation, Leukemic ; Humans ; Hypoxia ; Immunohistochemistry ; Interleukin-8/metabolism ; Leukemia, Myeloid, Acute/metabolism ; Leukemia, Myeloid, Acute/pathology ; Leukemia, Promyelocytic, Acute/genetics ; Leukemia, Promyelocytic, Acute/metabolism ; Leukemia, Promyelocytic, Acute/pathology ; Male ; Mesenchymal Stem Cells/metabolism ; Middle Aged ; Prognosis ; Reverse Transcriptase Polymerase Chain Reaction ; Survival Analysis ; Young Adult
Czasopismo naukowe
Tytuł:
Microenvironmental hypoxia regulates FLT3 expression and biology in AML.
Autorzy:
Sironi S; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Wagner M; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Kuett A; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Drolle H; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Polzer H; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.; Clinical Cooperation Group Leukemia, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Spiekermann K; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.; Clinical Cooperation Group Leukemia, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rieger C; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Fiegl M; Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2015 Nov 30; Vol. 5, pp. 17550. Date of Electronic Publication: 2015 Nov 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Leukemic*
Hypoxia/*genetics
Hypoxia/*metabolism
Leukemia, Myeloid, Acute/*genetics
Leukemia, Myeloid, Acute/*metabolism
Tumor Microenvironment/*genetics
fms-Like Tyrosine Kinase 3/*genetics
Blood Gas Analysis ; Cell Line, Tumor ; Down-Regulation ; Gene Expression ; Humans ; Leukemia, Myeloid, Acute/mortality ; Mutation ; Oxygen Consumption ; Prognosis ; Transfection ; fms-Like Tyrosine Kinase 3/metabolism
Czasopismo naukowe
Tytuł:
Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).
Autorzy:
Hilbe W; Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria.
Pall G; Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria.
Kocher F; Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria; Tyrolean Cancer Research Institute, Innsbruck, Austria.
Pircher A; Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria.
Zabernigg A; Department of Internal Medicine, County Hospital Kufstein, Kufstein, Austria.
Schmid T; Department of Surgery, Medical University Innsbruck, Innsbruck, Austria.
Schumacher M; Department of Pneumology, General Hospital, Elisabethinen Linz, Linz, Austria.
Jamnig H; Department of Pneumology, County Hospital Natters, Natters, Austria.
Fiegl M; Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria.
Gächter A; Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria.
Freund M; Department of Radiology, Medical University Innsbruck, Innsbruck, Austria.
Kendler D; Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
Manzl C; Department of Pathology, Medical University Innsbruck, Innsbruck, Austria.
Zelger B; Department of Pathology, Medical University Innsbruck, Innsbruck, Austria.
Popper H; Department of Pathology, Medical University Innsbruck, Innsbruck, Austria; Department of Pathology, Medical University Graz, Graz, Austria.
Wöll E; Department of Internal Medicine, Saint Vincent Hospital Zams, Zams, Austria.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 May 28; Vol. 10 (5), pp. e0125364. Date of Electronic Publication: 2015 May 28 (Print Publication: 2015).
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Carcinoma, Non-Small-Cell Lung/*drug therapy
Carcinoma, Non-Small-Cell Lung/*surgery
Induction Chemotherapy/*methods
Lung Neoplasms/*drug therapy
Lung Neoplasms/*surgery
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carcinoma, Non-Small-Cell Lung/pathology ; Cetuximab/administration & dosage ; Cetuximab/adverse effects ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Docetaxel ; Drug Administration Schedule ; Female ; Humans ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Survival Analysis ; Taxoids/administration & dosage ; Taxoids/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Physiological hypoxia prevents bile salt-induced apoptosis in human and rat hepatocytes.
Autorzy:
Hohenester S; Department of Medicine II, University of Munich, Munich, Germany.
Vennegeerts T
Wagner M
Wimmer R
Drolle H
Rieger C
Denk GU
Rust C
Fiegl M
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2014 Sep; Vol. 34 (8), pp. 1224-31. Date of Electronic Publication: 2013 Nov 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Apoptosis/*physiology
Cell Cycle Checkpoints/*physiology
Cell Hypoxia/*physiology
Hepatocytes/*physiology
Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism
Animals ; Apoptosis/drug effects ; Bile Acids and Salts/adverse effects ; Blotting, Western ; Cell Cycle Checkpoints/drug effects ; Flow Cytometry ; Hep G2 Cells ; Humans ; Microarray Analysis ; Rats ; Signal Transduction/physiology
Czasopismo naukowe
Tytuł:
Rituximab: how evidence based medicine can change our clinical practice.
Autorzy:
Mian M; Department of Hematology & Oncology, Medical University of Innsbruck , Innsbruck .
Gritsch S
Wasle I
Zabernigg A
Fiegl M
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2014 Jul; Vol. 55 (7), pp. 1694-6. Date of Electronic Publication: 2014 Feb 04.
Typ publikacji:
Letter
MeSH Terms:
Evidence-Based Medicine*
Practice Patterns, Physicians'*
Antineoplastic Agents/*therapeutic use
Immunologic Factors/*therapeutic use
Rituximab/*therapeutic use
Antineoplastic Agents/pharmacology ; Humans ; Immunologic Factors/pharmacology ; Rituximab/pharmacology
Opinia redakcyjna
Tytuł:
Prognostic and predictive value of cell cycle deregulation in non-small-cell lung cancer.
Autorzy:
Sterlacci W; Institute of Pathology, Feldkirch Academic Hospital, Affiliation of the Innsbruck Medical University, Feldkirch, Austria.
Fiegl M
Tzankov A
Pokaż więcej
Źródło:
Pathobiology : journal of immunopathology, molecular and cellular biology [Pathobiology] 2012; Vol. 79 (4), pp. 175-94. Date of Electronic Publication: 2012 Mar 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cell Cycle*
Carcinoma, Non-Small-Cell Lung/*pathology
Cyclins/*metabolism
Lung Neoplasms/*pathology
Biomarkers, Tumor/metabolism ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/mortality ; Humans ; Lung Neoplasms/metabolism ; Lung Neoplasms/mortality ; Predictive Value of Tests ; Prognosis
Czasopismo naukowe
Tytuł:
Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown.
Autorzy:
Kurz K; Division of Biological Chemistry, Biocenter, Medical University, Innsbruck, Austria.
Fiegl M
Holzner B
Giesinger J
Pircher M
Weiss G
Denz HA
Fuchs D
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (5), pp. e36956. Date of Electronic Publication: 2012 May 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Fatigue/*metabolism
Lung Neoplasms/*metabolism
Tryptophan/*metabolism
Anemia/blood ; Anemia/metabolism ; Anemia/physiopathology ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/metabolism ; Fatigue/blood ; Female ; Humans ; Inflammation/blood ; Inflammation/metabolism ; Lung Neoplasms/blood ; Male ; Neoplasm Staging/methods ; Psychological Tests ; Quality of Life
Czasopismo naukowe
Tytuł:
Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial.
Autorzy:
Fiegl M; Department of Internal Medicine V/Hematology-Oncoloy, Medical University of Innsbruck, Anichstrasse 35, Innsbruck, Austria. michael.fiegl@i-med.ac.at
Mlineritsch B
Hubalek M
Bartsch R
Pluschnig U
Steger GG
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2011 Aug 24; Vol. 11, pp. 373. Date of Electronic Publication: 2011 Aug 24.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibiotics, Antineoplastic/*therapeutic use
Breast Neoplasms/*drug therapy
Doxorubicin/*analogs & derivatives
Polyethylene Glycols/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Antibiotics, Antineoplastic/adverse effects ; Austria ; Breast Neoplasms/pathology ; Cohort Studies ; Disease-Free Survival ; Doxorubicin/adverse effects ; Doxorubicin/therapeutic use ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Neoplasm Metastasis ; Palliative Care ; Polyethylene Glycols/adverse effects
Czasopismo naukowe
Tytuł:
Noninvasive detection of lung cancer by analysis of exhaled breath.
Autorzy:
Bajtarevic A; Department of Operative Medicine, Innsbruck Medical University, A-6020 Innsbruck, Austria. />Ager C
Pienz M
Klieber M
Schwarz K
Ligor M
Ligor T
Filipiak W
Denz H
Fiegl M
Hilbe W
Weiss W
Lukas P
Jamnig H
Hackl M
Haidenberger A
Buszewski B
Miekisch W
Schubert J
Amann A
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2009 Sep 29; Vol. 9, pp. 348. Date of Electronic Publication: 2009 Sep 29.
Typ publikacji:
Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breath Tests/*methods
Gas Chromatography-Mass Spectrometry/*methods
Lung Neoplasms/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Exhalation ; Female ; Humans ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Invasiveness ; Young Adult
Czasopismo naukowe
Tytuł:
Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic score.
Autorzy:
Strasser-Weippl K; First Medical Department with Medical Oncology, Wilhelminen Hospital, Vienna, Austria.
Steurer M
Kees M
Augustin F
Tzankov A
Dirnhofer S
Fiegl M
Simonitsch-Klupp I
Zojer N
Gisslinger H
Ludwig H
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2006 Mar; Vol. 47 (3), pp. 441-50.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Severity of Illness Index*
Hemoglobins/*analysis
Primary Myelofibrosis/*complications
Adult ; Age Factors ; Aged ; Aged, 80 and over ; Cohort Studies ; Diagnosis, Differential ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Predictive Value of Tests ; Primary Myelofibrosis/diagnosis ; Primary Myelofibrosis/pathology ; Prognosis ; Risk Factors ; Survival Analysis
Czasopismo naukowe
Tytuł:
Burkitt's lymphoma of the stomach: a case report with molecular cytogenetic analysis.
Autorzy:
Krugmann J; Institute of Pathology, University of Innsbruck, Austria. />Tzankov A
Fiegl M
Dirnhofer S
Siebert R
Erdel M
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2004 May; Vol. 45 (5), pp. 1055-9.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Burkitt Lymphoma/*diagnosis
Stomach Neoplasms/*diagnosis
Adult ; Cytogenetic Analysis ; Fatal Outcome ; Humans ; Immunoglobulin Heavy Chains/genetics ; Immunophenotyping ; Male ; Oncogene Proteins, Fusion/analysis ; Proto-Oncogene Proteins c-myc/genetics
Czasopismo naukowe
Tytuł:
Blood dissemination of mammaglobin-specific RNA during core needle biopsy in patients with invasive breast carcinoma.
Autorzy:
Grünewald K
Haun M
Fiegl M
Gastl G
Marth C
Frede T
Pokaż więcej
Źródło:
The breast journal [Breast J] 2004 Jan-Feb; Vol. 10 (1), pp. 61-2.
Typ publikacji:
Evaluation Study; Letter
MeSH Terms:
Neoplastic Cells, Circulating*
Biomarkers, Tumor/*blood
Breast Neoplasms/*blood
Biomarkers, Tumor/genetics ; Biopsy, Needle ; Breast Neoplasms/pathology ; Female ; Humans ; Mammaglobin A ; Neoplasm Invasiveness ; Neoplasm Proteins/genetics ; Predictive Value of Tests ; RNA/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Uteroglobin/genetics
Opinia redakcyjna
    Wyświetlanie 1-18 z 18

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies